The invention relates to a
medicine for treating
viral myocarditis. The
medicine is prepared from the following medicinal raw materials in parts by weight: 22 parts of
ludwigia octovalvis, 12 parts of
scutellaria indica, 30 parts of
tetrapanax papyrierus, 12 parts of radix grewiae bilobae, 20 parts of
galium elegans, 1 part of
millettia bonatiana, 18 parts of
ammannia arenaria, 4 parts of
juncus bufonius and 12 parts of alnus cremastogyne. By applying the
medicine, the
ludwigia octovalvis has the effects of clearing heat, inducing
diuresis, removing
toxicity and diminishing swelling; the
scutellaria indica has the effects of clearing heat, removing
toxicity, promoting
blood circulation, relieving pain, stopping bleeding and diminishing swelling; the
tetrapanax papyrierus has the effects of clearing heat, inducing
diuresis, promoting qi circulation, promoting
digestion and promoting
blood circulation and
lactation; the radix grewiae bilobae has the effects of tonifying the
spleen and qi, dispelling wind and eliminating dampness; the
galium elegans has the effects of promoting
blood circulation, relaxing muscles and tendons, removing
blood stasis, promoting tissue regeneration and regulating qi and blood; the
millettia bonatiana has the effects of dispelling wind, eliminating dampness, promoting blood circulation and stopping bleeding; the
ammannia arenaria has the effects of tonifying the
spleen, inducing
diuresis, promoting qi circulation and eliminating stasis; the
juncus bufonius has the effects of clearing heat, dredging stranguria, inducing diuresis and stopping bleeding; and the alnus cremastogyne has the effects of clearing heat, cooling blood and removing
toxicity. The medicinal materials are combined to achieve the effects of tonifying the
spleen, calming, nourishing blood, tranquilizing, regulating qi and promoting blood circulation. Clinical experiments prove that the medicine can be used for safely and effectively treating
viral myocarditis.